You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 7, July 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Studies
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Exogenous Nonphysiologic vs Physiologic Lipids

Divergent Mechanisms for Correction of Permeability Barrier Dysfunction

Man Mao-Qiang, MD; Barbara E. Brown; Suzanna Wu-Pong, PhD; Kenneth R. Feingold, MD; Peter M. Elias, MD

Arch Dermatol. 1995;131(7):809-816.


Abstract

Background and Design
Although barrier function requires cholesterol, free fatty acids, and ceramides, applications of one or two of these lipids to damaged skin impedes barrier recovery, while equimolar mixtures allow normal recovery. Both incomplete and complete mixtures appear to be internalized within the epidermal nucleated layers, followed by the secretion of abnormal vs normal lamellar body contents, respectively. We compared the ability of complete physiologic lipid mixtures vs a nonmetabolized hydrophobic lipid, petrolatum, to repair the barrier and the requirement for intracellular processing of these lipids within the epidermis.

Results
Neat petrolatum, which remains restricted to the stratum corneum, produces more rapid improvement in barrier function than the solvent-dispersed physiologic lipids, and its effects are not altered by coapplication of either monensin or brefeldin A (both from Sigma Chemi- cal Co, St Louis, Mo), known inhibitors of exocytosis and organellogenesis, respectively. In contrast, the physiologic lipids enter the nucleated layers in substantial amounts and require longer to produce barrier recovery. Whereas monensin blocks their ability to facilitate barrier recovery, the physiologic lipids overcome brefeldin A—induced delays in barrier recovery, bypassing the subcellular site of brefeldin A blockade, normalizing both lamellar body contents and intercellular bilayers.

Conclusions
While petrolatum remains restricted to the stratum corneum, physiologic lipid mixtures influence barrier recovery after transport to subjacent, nucleated layers, followed by internalization, apparent transport to the distal Golgi apparatus, and incorporation into nascent lamellar bodies.

(Arch Dermatol. 1995;131:809-816)



Author Affiliations

From the Dermatology Service (Drs Mao-Qiang, Wu-Pong, Feingold, and Elias and Ms Brown) and Metabolism Section (Drs Wu-Pong and Feingold), Veterans Affairs Medical Center; and Departments of Dermatology (Drs Mao-Qiang, Wu-Pong, Feingold, Elias, and Ms Brown) and Medicine (Drs Wu-Pong and Feingold), University of California-San Francisco.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Skin Barrier Therapy on Neonatal Mortality Rates in Preterm Infants in Bangladesh: A Randomized, Controlled, Clinical Trial
Darmstadt et al.
Pediatrics 2008;121:522-529.
ABSTRACT | FULL TEXT  

Acute Modulations in Permeability Barrier Function Regulate Epidermal Cornification: Role of Caspase-14 and the Protease-Activated Receptor Type 2
Demerjian et al.
Am. J. Pathol. 2008;172:86-97.
ABSTRACT | FULL TEXT  

Does the Tail Wag the Dog?: Role of the Barrier in the Pathogenesis of Inflammatory Dermatoses and Therapeutic Implications
Elias and Feingold
Arch Dermatol 2001;137:1079-1081.
FULL TEXT  

Ceramide-Dominant, Barrier-Repair Lipids Improve Childhood Atopic Dermatitis
Chamlin et al.
Arch Dermatol 2001;137:1110-1112.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.